R CHOP re treatment offers durable responses in patients with late relapse diffuse large b cell lymphoma, with a 2-year time ...
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial We conducted a retrospective ...
Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...
The study reported 10-year survival rates of 81.3% for ALL and 76.2% for AML post-HCT. Relapse and cGVHD were the primary causes of late mortality, with relapse contributing to 33.9% of ALL and 44.9% ...
Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue Ninety-nine patients with resectable ...
Timely donor lymphocyte infusion (DLI) following the detection of impending molecular relapse may significantly improve outcomes for patients with acute myeloid leukemia (AML) who undergo allogeneic ...
Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results